tirzepatide and weight loss for Medical Tirzepatide vs. Semaglutide for Weight

However, these medications also introduce new considerations for those trying to conceive or undergoing fertility treatments

The skeptical cardiologist, like most physicians, has always assumed that weight loss, whether accomplished by diet/exercise, bariatric surgery, or drugs would benefit obese patients since it lowers blood pressure, cholesterol and blood sugar levels

This guide walks you through exactly how the conversion from tirzepatide to semaglutide works: who should consider it, why, the dosing transition process, what side effects to expect, and how to maintain your weight loss and blood sugar progress throughout

Current FDA labeling for semaglutide products includes warnings or precautions involving: Acute pancreatitis Acute gallbladder disease Acute kidney injury due to volume depletion Severe gastrointestinal reactions Hypoglycemia when combined with insulin or insulin secretagogues Diabetic retinopathy complications in susceptible patients Serious hypersensitivity reactions Pulmonary aspiration risk during general anesthesia or deep sedation Semaglutide labeling also contains a boxed warning regarding thyroid C-cell tumors observed in rodents

Appetite suppression, & down 5lbs in 3 weeks

A few users mention issues with the patient portal interface and cancellation logistics, but overall satisfaction remains high